---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-24-010089"
form_type: "8-K"
ticker: "CODX"
cik: "0001692415"
company_name: "Co-Diagnostics, Inc."
filed_at: "2024-03-15T23:59:59+00:00"
generated_at: "2026-06-04T17:28:38.521597+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.4
calibrated_materiality_score: 0.4
confidence: "high"
source: SEC EDGAR
---

# Co-Diagnostics appoints Richard Abbott as President effective March 15, 2024

## Summary
- Richard Abbott, age 52, appointed President of Co-Diagnostics, effective March 15, 2024.
- He previously served as President of Advanced Conceptions, a wholly owned subsidiary acquired in December 2021.
- Through 50% ownership of Whiteknob LLC, he may earn up to 507,386 common shares and 166,503 warrants upon milestone achievements.
- Holds MBA from Wharton and MS/BS in Mechanical Engineering from Brigham Young University.

## SEC filing metadata
- accession: 0001493152-24-010089
- form_type: 8-K
- ticker: CODX
- cik: 0001692415
- company_name: Co-Diagnostics, Inc.
- filed_at: 2024-03-15T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.4
- calibrated_materiality_score: 0.4
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1692415/000149315224010089/0001493152-24-010089-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1692415/000149315224010089/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-24-010089
- JSON: https://secwatch.observer/filing/0001493152-24-010089.json
- Plain text: https://secwatch.observer/filing/0001493152-24-010089.txt

## Key facts
- Executive change
  Richard Abbott was appointed as President at Co-Diagnostics, Inc..
  - Action: appointed
  - Role: President
  source text: On March 15, 2024, the Board of Directors of Co-Diagnostics, Inc. (the “Company”) appointed Richard Abbott as President.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1692415/000149315224010089/0001493152-24-010089-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.